Assessment of influence of traditional cardiovascular risk factors and inflammation on arterial wall structural characteristics in psoriatic arthritis

Assessment of influence of traditional cardiovascular risk factors and inflammation on arterial wall structural characteristics in psoriatic arthritis

Assessment of influence of traditional cardiovascular risk factors and inflammation on arterial wall structural characteristics in psoriatic arthritis. Objective. To assess possibility of traditional cardiovascular risk (CVR) factors application as markers of subclinical atherosclerosis in pts with...

Full description

Bibliographic Details
Main Authors:	T V Korotaeva, E Y Loginova, E S Mach, D S Novikova, E N Alexandrova, E L Nasonov, N N Firsov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2009-08-01
Series:	Научно-практическая ревматология
Subjects:	psoriatic arthritis traditional cardiovascular risk factors common carotid arteries intima-media complex thickness crp fibrinogen
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1060

Similar Items

The Association of Psoriatic Arthritis with Carotid Intima-Media Thickness
by: Hamidreza Talari, et al.
Published: (2021-03-01)

PREVALENCE OF METABOLIC SYNDROME IN PATIENTS WITH PSORIATIC ARTHRITIS: ITS ASSOCIATION WITH INFLAMMATION AND SUBCLINICAL ATHEROSCLEROSIS
by: E. I. Markelova, et al.
Published: (2016-09-01)

THE PREVALENCE OF TRADITIONAL CARDIOVASCULAR RISK FACTORS, SUBCLINICAL CAROTID ATHEROSCLEROSIS, CORONARY ARTERY CALCIFICATION IN PATIENTS WITH EARLY PSORIATIC ARTHRITIS (A REMARCA STUDY
by: E. I. Markelova, et al.
Published: (2018-05-01)

Dynamics of Carotid Intima-Media Thickness, Parameters of Arterial Stiffness and Ambulatory Blood Pressure Monitoring during Therapy with Inhibitor of Tumor Necrosis Factor-Alpha in Patients with Early Psoriatic Arthritis
by: E. I. Markelova, et al.
Published: (2018-11-01)

Usefullnes of atherogenic indices and Ca-LDL level to predict subclinical atherosclerosis in patients with psoriatic arthritis?
by: Duygu Tecer, et al.
Published: (2019-11-01)

Nail disease in psoriatic arthritis. Data from the Russian Psoriatic Arthritis Registry
by: E. E. Gubar, et al.
Published: (2021-10-01)

Clinical implication of assessment of heart rate variability in patients with psoriatic arthritis
by: D S Novikova, et al.
Published: (2009-06-01)

Rheological blood properties in psoriatic arthritis: relationship with inflammation and cardiovascular risk
by: T V Korotaeva, et al.
Published: (2009-10-01)

THE EFFECT OF AN ANTI-TUMOR NECROSIS FACTOR-? AGENT ON DISEASE ACTIVITY,BLOOD RHEOLOGICAL PROPERTIES, AND THE ARTERIAL WALL IN PSORIATIC ARTHRITIS
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2010-06-01)

Cardiovascular risk in patients with psoriatic arthritis
by: T V Korotaeva, et al.
Published: (2016-05-01)

Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors
by: Rodolfo A. Kolliker Frers, et al.
Published: (2018-02-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
by: T. V. Korotaeva, et al.
Published: (2015-10-01)

Cardiovascular risk in psoriatic arthritis
by: V V Badokin, et al.
Published: (2009-06-01)

CLINICAL EXPERIENCE WITH USTEKINUMAB IN THE TREATMENT OF EARLY PSORIATIC ARTHRITIS USING TREAT-TO-TARGET STRATEGY
by: E. Yu. Loginova, et al.
Published: (2015-09-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

A new integral enthesial-comorbididity index of psoriatic arthritis activity
by: Yulia L. Korsakova, et al.
Published: (2023-07-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2016-12-01)

TREAT-TO-TARGET STRATEGY FOR EARLY PSORIATIC ARTHRITIS (PRELIMINARY RESULTS OF THE REMARCА STUDY)
by: T. V. Korotaeva, et al.
Published: (2014-09-01)

Can the development of psoriatic arthritis be prevented in patients with psoriasis?
by: E. L. Nasonov, et al.
Published: (2019-07-01)

The burden of progression of psoriatic arthritis. All-Russian register data
by: Yulia L. Korsakova, et al.
Published: (2022-06-01)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Comparative characteristics of early psoriatic arthritis with and without axial skeleton injury (a subanalysis of the all-Russian registry of patients with psoriatic arthritis)
by: E. E. Gubar, et al.
Published: (2019-12-01)

SYSTEMIC OSTEOPOROSIS AND PSORIATIC ARTHRITIS: CURRENT UNDERSTANDING OF THE PROBLEM
by: O. V. Dobrovolskaya, et al.
Published: (2017-10-01)

IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01)

The duration of remission and minimal disease activity after initiation and discontinuation of biological agents in patients with early psoriatic arthritis (data from the all-russian psoriatic arthritis registry)
by: E. Yu. Loginova, et al.
Published: (2019-11-01)

Clinical and instrumental characteristics of axial involvement in psoriatic arthritis in real-life clinical practice
by: E. E. Gubar, et al.
Published: (2022-09-01)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)

Administration of phospholipide hepatoprotective drug Phosphogliv in patients with psoriatic arthritis (preliminary results)
by: T. V. Korotaeva, et al.
Published: (2004-06-01)

Effect of tofacitinib treatment on active MRI sacroiliitis in psoriatic arthritis patients
by: E. E. Gubar, et al.
Published: (2021-05-01)

The prevalence of comorbid and concomitant diseases in psoriatic arthritis patients, data from Russian register
by: Yu. L. Korsakova, et al.
Published: (2021-07-01)

Psoriatic arthritis: imaging techniques
by: E. Lubrano, et al.
Published: (2012-06-01)

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
by: E. I. Markelova, et al.
Published: (2019-11-01)

PSORIATIC ARTHRITIS: CLASSIFICATION, CLINICAL PRESENTATION, DIAGNOSIS, TREATMENT
by: T. V. Korotaeva
Published: (2014-12-01)

EFFECT OF SUBCUTANEOUS METHOTREXATE ON THE STRUCTURE AND FUNCTION OF THE VASCULAR WALL IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L. A. Knyazeva, et al.
Published: (2015-09-01)

Results of one-year treat-to-target strategy in early psoriatic arthritis: data of an open-label REMARCA study
by: T V Korotaeva, et al.
Published: (2018-05-01)

Psoriatic erythroderma: comparative patient profile and association with psoriatic arthritis
by: Elena V. Bogdanova
Published: (2023-01-01)

EVALUATION OF EFFECTIVENESS OF INFLUENCE OF THE SUBCUTANEOUS FORM OFMETHOTREXATUM TO THE LEVEL OF PRO-INFLAMMATORY CYTOKINEMIA AND THE MORPHOFUNCTIONAL STATE OF VASCULAR WALL IN PATIENTS WITH RHEUMATOID ARTHRITIS
by: L.A. KNYAZEVA, et al.
Published: (2017-04-01)

Psoriatic arthritis: pathogenetic features and innovative therapies
by: A. M. Lila, et al.
Published: (2019-01-01)

Cytokine profile in psoriatic arthritis: search for relationships with inflammation and blood rheological properties
by: Tat'yana Viktorovna Korotaeva, et al.
Published: (2011-02-01)

Prospects for the use of monoclonal antibodies to interleukin 23 Gusеlkumab in psoriatic arthritis: New data
by: E. L. Nasonov, et al.
Published: (2022-03-01)